Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

768 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM, Purdy JA, Winter K, Roach M 3rd, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD. Michalski JM, et al. Among authors: vijayakumar s. Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):391-402. doi: 10.1016/s0360-3016(99)00443-5. Int J Radiat Oncol Biol Phys. 2000. PMID: 10661346 Clinical Trial.
RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?
Valicenti RK, Winter K, Cox JD, Sandler HM, Bosch W, Vijayakumar S, Michalski J, Purdy J. Valicenti RK, et al. Among authors: vijayakumar s. Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):614-20. doi: 10.1016/s0360-3016(03)00640-0. Int J Radiat Oncol Biol Phys. 2003. PMID: 14529764 Clinical Trial.
Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
Luo C, Yang CC, Narayan S, Stern RL, Perks J, Goldberg Z, Ryu J, Purdy JA, Vijayakumar S. Luo C, et al. Among authors: vijayakumar s. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1253-62. doi: 10.1016/j.ijrobp.2006.06.010. Int J Radiat Oncol Biol Phys. 2006. PMID: 17145540 Clinical Trial.
Introducing new technologies into the clinic.
Vijayakumar S, Narayan S, Yang CC, Boerner P, Jacob R, Mathai M, Harse R, Purdy J. Vijayakumar S, et al. Front Radiat Ther Oncol. 2007;40:180-192. doi: 10.1159/000106035. Front Radiat Ther Oncol. 2007. PMID: 17641509 Review.
Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy.
Narayan S, Lehmann J, Coleman MA, Vaughan A, Yang CC, Enepekides D, Farwell G, Purdy JA, Laredo G, Nolan K, Pearson FS, Vijayakumar S. Narayan S, et al. Among authors: vijayakumar s. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):756-62. doi: 10.1016/j.ijrobp.2008.01.060. Epub 2008 Apr 15. Int J Radiat Oncol Biol Phys. 2008. PMID: 18417299
Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer.
Hall WH, Guiou M, Lee NY, Dublin A, Narayan S, Vijayakumar S, Purdy JA, Chen AM. Hall WH, et al. Among authors: vijayakumar s. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1362-7. doi: 10.1016/j.ijrobp.2008.03.004. Epub 2008 Apr 28. Int J Radiat Oncol Biol Phys. 2008. PMID: 18448267
768 results